Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AUTOPHAGY-LYSOSOME PATHWAY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
| Name | AUTOPHAGY-LYSOSOME PATHWAY |
| Key Genes/Proteins | AMPK, C9orf72, NLRP3, SQSTM1, TARDBP, TBK1 |
| Related Diseases | AMYOTROPHIC LATERAL SCLEROSIS, AUTOPHAGY, DEMENTIA, FRONTOTEMPORAL DEMENTIA, MITOPHAGY |
Knowledge base pages for this entity
graph TD
AUTOPHAGY_LYSOSOME_PATHWAY["AUTOPHAGY-LYSOSOME PATHWAY"]
AUTOPHAGY_LYSOSOME_PATHWAY -->|"degrades"| NLRP3["NLRP3"]
AUTOPHAGY_LYSOSOME_PATHWAY -->|"degrades"| SCIN["SCIN"]
AUTOPHAGY_LYSOSOME_PATHWAY -->|"involved_in"| Glucocorticoid_Induced_Muscle_["Glucocorticoid-Induced Muscle Atrophy"]
AUTOPHAGY_LYSOSOME_PATHWAY -->|"regulates"| alpha_synuclein["alpha-synuclein"]
Schaftoside["Schaftoside"] -->|"activates"| AUTOPHAGY_LYSOSOME_PATHWAY
extracellular_matrix_remodelin["extracellular matrix remodeling"] -->|"enhances"| AUTOPHAGY_LYSOSOME_PATHWAY
CAMK2D["CAMK2D"] -->|"regulates"| AUTOPHAGY_LYSOSOME_PATHWAY
ASTROCYTE["ASTROCYTE"] -->|"regulates"| AUTOPHAGY_LYSOSOME_PATHWAY
Obestatin["Obestatin"] -->|"regulates"| AUTOPHAGY_LYSOSOME_PATHWAY
MTOR["MTOR"] -->|"regulates"| AUTOPHAGY_LYSOSOME_PATHWAY
mTOR["mTOR"] -->|"regulates"| AUTOPHAGY_LYSOSOME_PATHWAY
alpha_synuclein -->|"inhibits"| AUTOPHAGY_LYSOSOME_PATHWAY| Target | Relation | Type | Str |
|---|---|---|---|
| NLRP3 | degrades | protein | 0.90 |
| TDP-43 Aggregation | involved_in | mechanism | 0.85 |
| SCIN | degrades | protein | 0.85 |
| Glucocorticoid-Induced Muscle Atrophy | involved_in | disease | 0.80 |
| NLRP3 | regulates | protein | 0.70 |
| alpha-synuclein | regulates | protein | 0.70 |
| Parkinson's disease | associated_with | disease | 0.70 |
| FRONTOTEMPORAL DEMENTIA | associated_with | disease | 0.45 |
| RAPAMYCIN | associated_with | drug | 0.45 |
| DEMENTIA | associated_with | disease | 0.45 |
| TDP-43 | associated_with | protein | 0.45 |
| SQSTM1 | associated_with | gene | 0.45 |
| TARDBP | associated_with | gene | 0.45 |
| NEURON | associated_with | cell_type | 0.45 |
| AMPK | associated_with | gene | 0.45 |
| TFEB | associated_with | gene | 0.45 |
| ULK1 | associated_with | gene | 0.45 |
| TBK1 | associated_with | gene | 0.45 |
| C9orf72 | associated_with | gene | 0.45 |
| NLRP3 | associated_with | gene | 0.45 |
| UBIQUITIN | associated_with | protein | 0.45 |
| MITOPHAGY | associated_with | phenotype | 0.45 |
| MICROGLIA | associated_with | cell_type | 0.45 |
| AUTOPHAGY | associated_with | phenotype | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| lnc-HIBADH-4/miR-326/CTSD | regulates | pathway | 0.90 |
| extracellular matrix remodeling | enhances | process | 0.90 |
| Schaftoside | activates | compound | 0.90 |
| TDP-43 | inhibits | protein | 0.90 |
| CAMK2D | regulates | protein | 0.85 |
| OBST | regulates | protein | 0.85 |
| C9ORF72 | dysregulates | gene | 0.80 |
| Obestatin | regulates | compound | 0.80 |
| Rapamycin | activates | drug | 0.80 |
| ASTROCYTE | regulates | cell_type | 0.80 |
| alpha-synuclein | inhibits | protein | 0.70 |
| MTOR | regulates | protein | 0.70 |
| mTOR | regulates | protein | 0.70 |
| FOXO1 | participates_in | gene | 0.62 |
| VCP | participates_in | gene | 0.49 |
| STX17 | participates_in | gene | 0.47 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | disease | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Transcriptional Autophagy-Lysosome Coupling | 0.882 | neurodegeneration | Autophagy-lysosome pathway convergence a |
| Early Proteasome Restoration Therapy | 0.712 | neurodegeneration | Gene expression changes in aging mouse b |
| Autophagosome Maturation Checkpoint Control | 0.709 | neurodegeneration | Autophagy-lysosome pathway convergence a |
| VCP-Mediated Autophagy Enhancement | 0.571 | Alzheimer's Disease | Tau propagation mechanisms and therapeut |
| HBOT (2.0 ATA, 60 min) activates TFEB-mediated autophagy-lys | 0.560 | neurodegeneration | What are the optimal oxygen pressure, du |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 15 hypotheses Top: 0.814
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.882
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Meta-analysis of LRP1 C766T polymorphism and Alzheimer's disease susce | exploratory | Alzheimer's disease | 0.950 | 0.00 | human patients | proposed | N/A |
| Endothelial CD2AP knockdown effects on memory in male mice | validation | Alzheimer's disease | 0.900 | 0.00 | male mice | proposed | N/A |
| Amyloid plaque load analysis in triple-mutant mouse brains | exploratory | Alzheimer's disease | 0.880 | 0.00 | APP/PSEN1/GD3S-/- triple-trans | proposed | N/A |
| Reelin treatment rescue via ApoER2 in CD2AP mutant mice | validation | Alzheimer's disease | 0.870 | 0.00 | mice | proposed | N/A |
| Network Pharmacology Analysis of Shared AD Targets | exploratory | Alzheimer's disease | 0.850 | 0.00 | Computational network analysis | proposed | N/A |
| MRI Phenotyping Method Concordance in Serbian AD Cohort | clinical | Alzheimer's disease | 0.850 | 0.00 | human patients | proposed | N/A |
| Endothelin-1 receptor A antagonist rescue in male CD2AP mice | validation | Alzheimer's disease | 0.850 | 0.00 | male mice | proposed | N/A |
| Endothelin-1 receptor A antagonist rescue experiment | validation | Alzheimer's disease | 0.850 | 0.00 | mice | proposed | N/A |
| Neuroimmune modulation and Aβ clearance mechanisms | exploratory | Alzheimer's disease | 0.820 | 0.00 | Microglia and astrocytes | proposed | N/A |
| Competing endogenous RNA (ceRNA) network construction | exploratory | Alzheimer's disease | 0.750 | 0.00 | computational network analysis | proposed | N/A |
| Autophagy Enhancement Drug Screening for Neurodegeneration | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Chaperone-Mediated Autophagy Dysfunction in PD - Experiment Design | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Macroautophagy Dysfunction in PD - Experiment Design | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Validate Mitochondria-Lysosome Contact Site Dysfunction in PD | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,730,000 |
| Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Val | validation | Neurodegeneration | 0.400 | 0.50 | human | proposed | $3,000,000 |
| MLCS Quantification in Parkinson's Disease | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,730,000 |
| Presymptomatic GRN Carrier Intervention Timing — Biomarker-Guided Ther | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism and Therapeu | validation | Neurodegeneration | 0.400 | 0.50 | human | proposed | $2,730,000 |
| ER-Golgi Secretory Pathway Dysfunction in PD - Experiment Design | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,500,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Autophagy and ALS: mechanistic insights and therapeutic implications. [PMID:34057020] | Chua JP, De Calbiac H, Kabashi E, Barmad | Autophagy | 2022 | 2 |
| Systemic Neurodegeneration and Brain Aging: Multi-Omics Disintegration, Proteost [PMID:40868276] | Voicu V, Toader C, Șerban M, Covache-Bus | Biomedicines | 2025 | 1 |
| Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammati [PMID:37678798] | Pan Q, Gao M, Kim D, Ai W, Yang W, Jiang | Cell Mol Gastroenterol Hepatol | 2024 | 1 |
| Acetylation in the regulation of autophagy. [PMID:35435793] | Xu Y, Wan W | Autophagy | 2023 | 1 |
| Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] | Zhang T, Xu D, Trefts E, Lv M, Inuzuka H | Science | 2023 | 1 |
| Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and inv [PMID:35176466] | Zhang L, Liang B, Xu H, Gong Y, Hu W, Ji | J Ethnopharmacol | 2022 | 1 |
| New insights regarding SNARE proteins in autophagosome-lysosome fusion. [PMID:32924745] | Tian X, Teng J, Chen J | Autophagy | 2021 | 1 |
| Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892] | Wang Y, An H, Liu T, Qin C, Sesaki H, Gu | Cell Rep | 2019 | 1 |
| AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310] | Song X, Zhu S, Chen P, Hou W, Wen Q, Liu | Curr Biol | 2018 | 1 |
| Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in gl [PMID:28675664] | Cid-Díaz T, Santos-Zas I, González-Sánch | J Cachexia Sarcopenia Muscle | 2017 | 1 |
| Autophagosomes form at ER-mitochondria contact sites. [PMID:23455425] | Hamasaki M, Furuta N, Matsuda A, Nezu A, | Nature | 2013 | 1 |
| Gut Microbiota-Derived Tyrosol Alleviates Radiation-Induced Intestinal Injury vi [PMID:41800257] | Jin X, Xue H, Shi X, Zhou Y, Zhang J, Ze | International journal of biolo | 2026 | 0 |
| PTEN loss drives B7H3 upregulation via the mTORC2/FOXO/c-Myc axis to promote tum [PMID:41920736] | Wang Z, Jin N, Li X, Ma X, Feng Y, Yin K | Cell reports | 2026 | 0 |
| SNX16 functions as a nutrient-sensitive regulator of autophagosomal components r [PMID:41593027] | Que H, Rong Y | Autophagy | 2026 | 0 |
| TMEM259/MEMBRALIN is a non-canonical ER-phagy receptor that associates with MAN1 [PMID:41799849] | Camilleri JM, Zhang J, Wang T, Ahmad I, | Autophagy reports | 2026 | 0 |
| Mammalian lipophagy: process and function. [PMID:41681129] | Zhao R, Dai E, Kang R, Liu J, Klionsky D | Autophagy | 2026 | 0 |
| TAZ alleviates ischemic stroke injury by activating Foxo1: Usp1-mediated deubiqu [PMID:41921828] | ["Xin Y", "Sun Y", "Pan E", "Li M", "Che | Free radical biology & medicin | 2026 | 0 |
| Unveiling the Genomic Landscape of Yan Goose (Anser cygnoides): Insights into Po [PMID:41594384] | Qi S, Ai Z, Cai Y, Zhang Y, Zhao W et al | Animals (Basel) | 2026 | 0 |
| Combining network pharmacology and multi-omics reveals the role of Shengdihuang- [PMID:41655545] | Cao X, Shang Y, Qu M, Kang Q, Xu Y et al | Phytomedicine | 2026 | 0 |
| Comparative transcriptomics of adherent and suspension chicken fibroblast cell l [PMID:41763754] | Contreras EJ, Nagarajan A, Bromberg BH, | Food Res Int | 2026 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.90 · 2026-04-12
closed · Rounds: 4 · Score: 0.90 · 2026-04-06
closed · Rounds: 3 · Score: 0.95 · 2026-04-04